Arvinas (ARVN) Amortization of Deferred Charges (2019 - 2026)

Arvinas (ARVN) recorded quarterly Amortization of Deferred Charges of $300000.0 in Q1 2026, up 50.0% quarter-over-quarter from $200000.0 in Q4 2025, and down 90.91% on a YoY basis from $3.3 million in Q1 2025.

Arvinas (ARVN) Amortization of Deferred Charges (2019 - 2026) Analysis & Trends

Arvinas' Amortization of Deferred Charges history runs 8 years deep, the most recent figure standing at $300000.0 for Q1 2026.

  • In Q1 2026, Amortization of Deferred Charges fell 90.91% year-over-year to $300000.0; the TTM figure through Mar 2026 stood at $1.3 million (down 82.67% YoY), while the FY2025 annual figure was $4.3 million, down 6.52% from the prior year.
  • Amortization of Deferred Charges was $300000.0 for Q1 2026 at Arvinas, up from $200000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $3.3 million in Q1 2025 to a low of -$700000.0 in Q4 2023.
  • Historically, Amortization of Deferred Charges has averaged $723529.4 across 5 years, with a median of $500000.0 in 2022.
  • The sharpest annual moves came in 2023 and 2025: Amortization of Deferred Charges sank 240.0% in 2023, then soared 725.0% in 2025.
  • A 5-year view of Amortization of Deferred Charges shows it stood at $500000.0 in 2022, then tumbled by 240.0% to -$700000.0 in 2023, then surged by 242.86% to $1.0 million in 2024, then plunged by 80.0% to $200000.0 in 2025, then jumped by 50.0% to $300000.0 in 2026.
  • The last three Amortization of Deferred Charges figures came in at $300000.0 (Q1 2026), $200000.0 (Q4 2025), and $400000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Arvinas 492.16 Mn -122.74 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 300,000.00
Mar 31, 2026 300,000.00
Dec 31, 2025 200,000.00
Dec 31, 2025 200,000.00
Sep 30, 2025 400,000.00
Sep 30, 2025 400,000.00
Jun 30, 2025 400,000.00
Jun 30, 2025 400,000.00
Mar 31, 2025 3.30 Mn
Mar 31, 2025 3.30 Mn
Dec 31, 2024 1.00 Mn
Dec 31, 2024 1.00 Mn
Sep 30, 2024 1.90 Mn
Sep 30, 2024 1.90 Mn
Jun 30, 2024 1.30 Mn
Jun 30, 2024 1.30 Mn
Mar 31, 2024 400,000.00
Mar 31, 2024 400,000.00
Dec 31, 2023 -700,000.00
Dec 31, 2023 -700,000.00